Intuitive Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Intuitive Biosciences's estimated annual revenue is currently $1.9M per year.
- Intuitive Biosciences's estimated revenue per employee is $155,000
Employee Data
- Intuitive Biosciences has 12 Employees.
- Intuitive Biosciences grew their employee count by 0% last year.
Intuitive Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Manufacturing | Reveal Email/Phone |
3 | VP Research and Development | Reveal Email/Phone |
Intuitive Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Intuitive Biosciences?
Intuitive Biosciences has been supporting biomedical research since 2012 by providing kits and services to monitor nonhuman primate health. In your lab our ours, our easy-to-use platform screens NHP blood samples for infectious diseases including tuberculosis and SARS-CoV-2. From routine SPF colony screening to antibody titer monitoring for vaccines, we can support your team and your research. We offer: a full immunoassay platform available as turnkey system or OEM including consumables, content, SilverQuant detection reagents, analysis instruments and reporting software. Join our email list for updates, specials, and new product launches! https://goo.gl/8kNszS
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 12 | 33% | N/A |
#2 | $1.9M | 12 | -8% | N/A |
#3 | $3M | 12 | N/A | N/A |
#4 | N/A | 12 | 50% | N/A |
#5 | $1M | 12 | 9% | N/A |